21 related articles for article (PubMed ID: 7685449)
1. A modified product inhibition model describes the nonlinear pharmacokinetics of nicorandil in rats.
Bachert EL; Li ZW; Zhao L; Chung SJ; Fung HL
Pharm Res; 1994 Aug; 11(8):1190-8. PubMed ID: 7971723
[TBL] [Abstract][Full Text] [Related]
2. Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim.
Noguchi K; Matsuzaki T; Ojiri Y; Koyama T; Nakasone J; Sakanashi M
Fundam Clin Pharmacol; 1998; 12(3):270-8. PubMed ID: 9646059
[TBL] [Abstract][Full Text] [Related]
3. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure.
Bauer JA; Fung HL
J Pharmacol Exp Ther; 1991 Jan; 256(1):249-54. PubMed ID: 1899118
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.
Tsutamoto T; Kinoshita M; Hisanaga T; Maeda Y; Maeda K; Wada A; Fukai D; Yoshida S
Am J Cardiol; 1995 Jun; 75(16):1162-5. PubMed ID: 7762505
[TBL] [Abstract][Full Text] [Related]
5. Comparison of development of tolerance between nicorandil and nitroglycerin in anesthetized, open-chest dogs.
Kuromaru O; Sakai K
Jpn J Pharmacol; 1986 Oct; 42(2):199-208. PubMed ID: 2948042
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans.
Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE
J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713
[TBL] [Abstract][Full Text] [Related]
7. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
Krumenacker M; Roland E
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
[TBL] [Abstract][Full Text] [Related]
8. [Ca-antagonist, K-channel-opener in the treatment of patients with congestive heart failure].
Satoh K
Nihon Rinsho; 1993 May; 51(5):1293-8. PubMed ID: 8331797
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic tolerance and pharmacokinetics of nicorandil in experimental heart failure.
Bachert EL; Fung HL
J Cardiovasc Pharmacol; 1993 May; 21(5):781-5. PubMed ID: 7685449
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic and clinical effects of an intravenous potassium channel opener--a review.
Kato K
Eur Heart J; 1993 Jul; 14 Suppl B():40-7. PubMed ID: 8370372
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
